Protocols

The available evidence provides limited information about specific dosing and administration protocols for NR (nicotinamide riboside). Based on the clinical trials identified in the literature search, several studies have investigated NR supplementation, but detailed protocol information is not provided in these search results.

The completed and ongoing trials include:

Exercise-related studies: Two completed trials examined NR supplementation in combination with exercise therapy, including one focused on hypertensive older adults (NCT04112043, Phase 1) and another general exercise supplementation study (NCT04907110).
Neurological applications: One ongoing Phase 2 trial (NCT06162013) is investigating NAD replenishment therapy for atypical Parkinsonism.
Sleep research: One planned study (NCT07284225) will examine acute effects of NR on sleep structure in healthy adults.

However, the search results do not contain the actual dosing regimens, administration schedules, or specific protocols used in these studies. The abstracts and trial listings available do not provide sufficient detail about:

Specific dosages tested
Duration of treatment
Frequency of administration
Route of administration
Patient selection criteria
Monitoring requirements

Important Disclaimer: This information is provided for educational purposes only and represents a limited review of available literature. This is not personalized medical advice. Any decisions regarding NR supplementation should be made in consultation with qualified healthcare providers who can assess individual medical history, current medications, and specific health needs.

To obtain detailed protocol information, access to the full study publications or trial protocols would be necessary.

NR

Member access required